Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 112

    1.

    Altered natural killer cells in type 1 diabetic patients.

    Rodacki M, Svoren B, Butty V, Besse W, Laffel L, Benoist C, Mathis D.

    Diabetes. 2007 Jan;56(1):177-85.PMID: 17192480 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Identical twins discordant for type 1 diabetes show a different pattern of in vitro CD56+ cell activation.

    Goodier MR, Nawroly N, Beyan H, Hawa M, Leslie RD, Londei M.

    Diabetes Metab Res Rev. 2006 Sep-Oct;22(5):367-75.PMID: 16572491 [PubMed - indexed for MEDLINE]Related articles

    3.

    Critical role for IFN-gamma in natural killer cell-mediated protection from diabetes.

    Lee IF, Qin H, Priatel JJ, Tan R.

    Eur J Immunol. 2008 Jan;38(1):82-9.PMID: 18085661 [PubMed - indexed for MEDLINE]Related articles

    4.

    Evidence that the reduced number of natural killer cells in type 1 (insulin-dependent) diabetes may be genetically determined.

    Hussain MJ, Alviggi L, Millward BA, Leslie RD, Pyke DA, Vergani D.

    Diabetologia. 1987 Dec;30(12):907-11.PMID: 3436487 [PubMed - indexed for MEDLINE]Related articles

    5.

    NKG2D-RAE-1 receptor-ligand variation does not account for the NK cell defect in nonobese diabetic mice.

    Maier LM, Howlett SK, Rainbow KM, Clark J, Howson JM, Todd JA, Wicker LS.

    J Immunol. 2008 Nov 15;181(10):7073-80.PMID: 18981127 [PubMed - indexed for MEDLINE]Related articlesFree article

    6.

    High frequency of valpha24(+) vbeta11(+) T-cells observed in type 1 diabetes.

    Oikawa Y, Shimada A, Yamada S, Motohashi Y, Nakagawa Y, Irie J, Maruyama T, Saruta T.

    Diabetes Care. 2002 Oct;25(10):1818-23.PMID: 12351484 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Natural killer cell and islet killer cell activities in type 1 (insulin-dependent) diabetes.

    Negishi K, Waldeck N, Chandy G, Buckingham B, Kershnar A, Fisher L, Gupta S, Charles MA.

    Diabetologia. 1986 Jun;29(6):352-7.PMID: 3527835 [PubMed - indexed for MEDLINE]Related articles

    8.

    Conferral of enhanced natural killer cell function by KIR3DS1 in early human immunodeficiency virus type 1 infection.

    Long BR, Ndhlovu LC, Oksenberg JR, Lanier LL, Hecht FM, Nixon DF, Barbour JD.

    J Virol. 2008 May;82(10):4785-92. Epub 2008 Feb 27.PMID: 18305035 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Natural killer cell and islet killer cell activities in human type 1 diabetes.

    Negishi K, Waldeck N, Chandy G, Buckingham B, Kershnar A, Fisher L, Gupta S, Charles AM.

    Exp Clin Endocrinol. 1987 Aug;89(3):345-53.PMID: 3311777 [PubMed - indexed for MEDLINE]Related articles

    10.

    A subpopulation of human peripheral blood NK cells that lacks inhibitory receptors for self-MHC is developmentally immature.

    Cooley S, Xiao F, Pitt M, Gleason M, McCullar V, Bergemann TL, McQueen KL, Guethlein LA, Parham P, Miller JS.

    Blood. 2007 Jul 15;110(2):578-86. Epub 2007 Mar 28.PMID: 17392508 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Deficiency of monoclonal antibody (Leu 7) defined NK cells in newly diagnosed insulin-dependent diabetes mellitus.

    Chandy KG, Charles MA, Buckingham B, Waldeck N, Kershnar A, Gupta S.

    Immunol Lett. 1984;8(2):89-91.PMID: 6746020 [PubMed - indexed for MEDLINE]Related articles

    12.

    [The functional activity and count of the natural killer cells in patients with recently diagnosed diabetes mellitus types I and II]

    Salozhin KV, Sura VV, Nasonov EL, Korneeva MN, Smirnova OI.

    Ter Arkh. 1989;61(10):104-6. Russian. PMID: 2609254 [PubMed - indexed for MEDLINE]Related articles

    13.

    Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.

    Brillard E, Pallandre JR, Chalmers D, Ryffel B, Radlovic A, Seilles E, Rohrlich PS, Pivot X, Tiberghien P, Saas P, Borg C.

    Exp Hematol. 2007 Mar;35(3):416-25.PMID: 17309822 [PubMed - indexed for MEDLINE]Related articles

    14.

    Evaluation of the natural killer cytotoxicity and the levels of cytokines in rats with type I diabetes mellitus.

    Fidan I, Yüksel S, Kalkanci A, Imir T, Kustimur S.

    Mem Inst Oswaldo Cruz. 2005 Dec;100(8):883-7. Epub 2006 Jan 20.PMID: 16444420 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Interaction of monocytes with NK cells upon Toll-like receptor-induced expression of the NKG2D ligand MICA.

    Kloss M, Decker P, Baltz KM, Baessler T, Jung G, Rammensee HG, Steinle A, Krusch M, Salih HR.

    J Immunol. 2008 Nov 15;181(10):6711-9.PMID: 18981088 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Modelling KIR-HLA genotype disparities in type 1 diabetes.

    van der Slik AR, Alizadeh BZ, Koeleman BP, Roep BO, Giphart MJ.

    Tissue Antigens. 2007 Apr;69 Suppl 1:101-5.PMID: 17445178 [PubMed - indexed for MEDLINE]Related articles

    18.

    The expression of human natural killer cell receptors in early life.

    Sundström Y, Nilsson C, Lilja G, Kärre K, Troye-Blomberg M, Berg L.

    Scand J Immunol. 2007 Aug-Sep;66(2-3):335-44.PMID: 17635811 [PubMed - indexed for MEDLINE]Related articles

    19.

    NK cells and type 1 diabetes.

    Rodacki M, Milech A, de Oliveira JE.

    Clin Dev Immunol. 2006 Jun-Dec;13(2-4):101-7. Review.PMID: 17162353 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Find related data